# Michelle M. O’Shaughnessy

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/michelle-m-o-shaughnessy/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,434 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 29 |
| i10-index | 58 |
| Last Known Institution | Ollscoil na Gaillimhe – University of Galway |
| OpenAlex ID | https://openalex.org/A5003276959 |
| ORCID iD | 0000-0002-0406-1308 |
| Works | 130 |

## Researcher papers

- [Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference](https://scholariq.org/papers/atypical-hemolytic-uremic-syndrome-and-c3-glomerulopathy-conclusions-from-a/)
- [Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial](https://scholariq.org/papers/efficacy-and-safety-of-sparsentan-versus-irbesartan-in-patients-with-iga/)
- [Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/management-and-treatment-of-glomerular-diseases-part-1-conclusions-from-a-kidney/)
- [C3 Glomerulopathy](https://scholariq.org/papers/c3-glomerulopathy/)
- [Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey](https://scholariq.org/papers/glomerular-disease-frequencies-by-race-sex-and-region-results-from-the/)
- [Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial](https://scholariq.org/papers/sparsentan-in-patients-with-iga-nephropathy-a-prespecified-interim-analysis-from/)
- [Recurrence of FSGS after Kidney Transplantation in Adults](https://scholariq.org/papers/recurrence-of-fsgs-after-kidney-transplantation-in-adults/)
- [Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/management-and-treatment-of-glomerular-diseases-part-2-conclusions-from-a-kidney/)
- [Temporal and Demographic Trends in Glomerular Disease Epidemiology in the Southeastern United States, 1986–2015](https://scholariq.org/papers/temporal-and-demographic-trends-in-glomerular-disease-epidemiology-in-the/)
- [CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease](https://scholariq.org/papers/curegn-study-rationale-design-and-methods-establishing-a-large-prospective/)
- [Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA](https://scholariq.org/papers/differences-in-initial-treatment-modality-for-end-stage-renal-disease-among/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)

## Researcher university

- [Ollscoil na Gaillimhe – University of Galway](https://scholariq.org/institutions/ollscoil-na-gaillimhe-university-of-galway/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.